Cytovale Blackhorn Ventures Portfolio Company


Cytovale is a team of biologists, data scientists, and engineers, financiers and former care providers with a vision for how to make very complex, critical diseases come into sharp and present focus. Their novel microfluidic platform interrogates thousands of individual cells to quantify the mechanical signatures of disease. They are applying this first to sepsis, a condition whose early detection dramatically improves patient outcomes and preserves vital hospital resources.


Healthcare – Diagnostics